Chimeric Antigen Receptor (CAR) T-cell and bispecific antibody (BsAb) therapies have fundamentally changed the treatment landscape for multiple myeloma (MM), offering patients durable responses and new hope for disease control. However, these…
Immune Complications Increase Infection Risk in Advanced Multiple Myeloma Therapies
